MedAware Raises $1 Million to Bring Big Data Analytics to Medical Prescription Market
PR Newswire Association LLC |
RA'ANANA,
MedAware, a developer of big data analytics for the medical prescription market, announced today that it has completed a
Today, prescription errors result in morbidity, mortality and wasteful healthcare costs, harming hundreds of thousands of people annually in
"Three years ago I came across a tragic case of a nine-year-old Israeli boy who died because his primary-care physician accidentally prescribed the wrong drug," said MedAware Co-founder and CEO
Current solutions such as electronic medical records and computerized physician order entry systems search for prescription errors based on manually predefined rules. These systems miss errors that do not fall into their known rules, and also suffer from high false-alarm rates. By contrast, MedAware uses big-data analytics and machine-learning algorithms to automatically learn how different clinical scenarios are managed by physicians in real world situations.
"MedAware embodies many of the same technologies we've seen accompany the emergence of the Industrial Internet," added
"We are excited about the potential for MedAware to solve the huge problem of prescription error via their impressive big data technology," said
About MedAware
MedAware provides innovative solutions that save lives, improve patient safety and significantly reduce healthcare costs, by identifying and preventing prescription errors in real-time. MedAware's patent-pending technology uses big data analytics and machine learning algorithms to analyze large scale data of Electronic Medical Records (EMRs), to learn automatically how physicians treat patients in real life scenarios. Prescriptions largely deviating from the spectrum of standard treatment patterns are flagged as potential errors with high specificity and low "alert fatigue". MedAware was founded in 2012, and is headquartered in
About OurCrowd
OurCrowd is the leading hybrid venture capital equity crowdfunding platform for accredited investors who wish to invest in Israeli and global early stage companies. Managed by a team of well-known investment professionals and led by serial entrepreneur
About
Press contact:
Co-Founder and CEO
US tel. +1-617-648-0349
Israel Tel. +972-50-6701124
[email protected]
SOURCE MedAware
Wordcount: | 733 |
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News